首页 > 最新文献

Neurohospitalist最新文献

英文 中文
Feasibility of Percutaneous Gastrostomy Tube Placement Using Only Local Anesthetic in Patients With Neuromuscular Dysfunction. 神经肌肉功能障碍患者仅使用局部麻醉剂经皮胃管置入术的可行性。
IF 0.7 Q4 CLINICAL NEUROLOGY Pub Date : 2025-04-01 Epub Date: 2024-08-22 DOI: 10.1177/19418744241274507
Srinidhi Shanmugasundaram, Nardine Mikhail, Tarek Jazmati, Abhishek Kumar, Pratik A Shukla

Background: Patients with neuromuscular disorders often require gastrostomy tube placement for feeding but routinely have contraindication to sedation due to poor airway control with intubation avoided at the risk of ventilator dependence.

Purpose: To assess the feasibility of percutaneous gastrostomy tube (G-tube) placement using only local anesthesia in patients with neuromuscular dysfunction.

Research design: A retrospective chart review was performed from 2013 to 2019 for all patients who underwent percutaneous G-tube placement under local anesthesia only.

Study sample: 12 patients (6 females, 6 males; mean age = 52.3 ± 21.8) with neuromuscular disorders underwent G-tube placement with only local anesthesia.

Data collection: Data collected included demographic data, medical history (source of neuromuscular dysfunction), procedural information, and complications.

Results: Technical success was achieved in 100% of patients with no major complications.

Conclusion: Placement of a percutaneous gastrostomy tube using only local anesthesia is safe and feasible in patients who have a contraindication to sedation due to poor airway control and for whom intubation is avoided due to risk of ventilator dependence.

背景:目的:评估神经肌肉功能障碍患者仅使用局部麻醉进行经皮胃造瘘管(G管)置管的可行性.研究设计:研究样本:12 名神经肌肉功能障碍患者(6 名女性,6 名男性;平均年龄 = 52.3 ± 21.8)仅在局部麻醉下接受了经皮胃管置入术:收集的数据包括人口统计学数据、病史(神经肌肉功能障碍的来源)、手术信息和并发症:结果:100% 的患者技术成功,无重大并发症:结论:对于因气道控制不佳而禁用镇静剂的患者,以及因呼吸机依赖风险而避免插管的患者,仅使用局部麻醉置入经皮胃造瘘管是安全可行的。
{"title":"Feasibility of Percutaneous Gastrostomy Tube Placement Using Only Local Anesthetic in Patients With Neuromuscular Dysfunction.","authors":"Srinidhi Shanmugasundaram, Nardine Mikhail, Tarek Jazmati, Abhishek Kumar, Pratik A Shukla","doi":"10.1177/19418744241274507","DOIUrl":"10.1177/19418744241274507","url":null,"abstract":"<p><strong>Background: </strong>Patients with neuromuscular disorders often require gastrostomy tube placement for feeding but routinely have contraindication to sedation due to poor airway control with intubation avoided at the risk of ventilator dependence.</p><p><strong>Purpose: </strong>To assess the feasibility of percutaneous gastrostomy tube (G-tube) placement using only local anesthesia in patients with neuromuscular dysfunction.</p><p><strong>Research design: </strong>A retrospective chart review was performed from 2013 to 2019 for all patients who underwent percutaneous G-tube placement under local anesthesia only.</p><p><strong>Study sample: </strong>12 patients (6 females, 6 males; mean age = 52.3 ± 21.8) with neuromuscular disorders underwent G-tube placement with only local anesthesia.</p><p><strong>Data collection: </strong>Data collected included demographic data, medical history (source of neuromuscular dysfunction), procedural information, and complications.</p><p><strong>Results: </strong>Technical success was achieved in 100% of patients with no major complications.</p><p><strong>Conclusion: </strong>Placement of a percutaneous gastrostomy tube using only local anesthesia is safe and feasible in patients who have a contraindication to sedation due to poor airway control and for whom intubation is avoided due to risk of ventilator dependence.</p>","PeriodicalId":46355,"journal":{"name":"Neurohospitalist","volume":" ","pages":"133-135"},"PeriodicalIF":0.7,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11561909/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Myelin Oligodendrocyte Glycoprotein G Antibody-Positive Paraneoplastic Myelopathy in Seminoma: A Case Report and Literature Review. 精原细胞瘤中髓鞘寡突胶质细胞糖蛋白 G 抗体阳性的副肿瘤性骨髓病:病例报告和文献综述。
IF 0.7 Q4 CLINICAL NEUROLOGY Pub Date : 2025-04-01 Epub Date: 2024-09-26 DOI: 10.1177/19418744241288288
Umair Hamid, Jamir Pitton Rissardo, Luisa F Alviz, Ana Letícia Fornari Caprara, Tiffani S Franada

Myelin oligodendrocyte glycoprotein-associated disorders (MOGAD) are autoimmune diseases that often manifest in the context of infections. They can also arise less commonly following vaccination but even more rarely in a paraneoplastic context. Herein, we will report a patient presenting with subacute inflammatory myelopathy after a fourth dose of the mRNA COVID-19 vaccine. Concurrently, a diagnosis of MOGAD was made with a metastatic abdominal seminoma. The patient was acutely treated with high-dose steroids followed by plasma exchange therapy and was subsequently started on a chemotherapy regimen for the underlying germ cell tumor. The patient had a complete resolution of neurological symptoms upon the last follow-up. Overall, 72 cases of COVID-19 vaccination associated with MOGAD were analyzed (median age at onset 39 years old; female to male ratio = 1.2:1). All cases occurred in adults except for an adolescent, with the majority occurring after vaccination with ChAdOx nCoV-19 (87%), and an average temporal profile between vaccination and symptom onset of 19 days. There were no reported cases after the third or fourth doses, and most patients were diagnosed with new-onset MOGAD after their first vaccine (76%). Although COVID-19 vaccination could be a potential causality, there are significant discrepancies between the reported cases and this patient, alongside the unlikely causality assessment obtained with the Bradford Hill criteria. Vaccination could unmask potential pre-existing autoimmune diseases, such as in this patient, where myelopathy was most likely part of a paraneoplastic syndrome associated with a newly diagnosed seminoma.

髓鞘少突胶质细胞糖蛋白相关疾病(MOGAD)是一种自身免疫性疾病,通常表现为感染。它们也可能在接种疫苗后出现,但更罕见的是在副肿瘤背景下出现。在此,我们将报告一名在接种第四剂 mRNA COVID-19 疫苗后出现亚急性炎症性脊髓病的患者。与此同时,患者还被诊断为腹腔转移性精原细胞瘤(MOGAD)。患者接受了大剂量类固醇的急性治疗,随后进行了血浆置换治疗,随后开始对潜在的生殖细胞瘤进行化疗。最后一次随访时,患者的神经症状已完全消失。共分析了72例接种COVID-19疫苗后出现MOGAD的病例(发病时的中位年龄为39岁,男女比例为1.2:1)。除一名青少年外,所有病例均发生在成年人身上,大多数病例发生在接种 ChAdOx nCoV-19 疫苗之后(87%),接种疫苗与发病之间的平均时间间隔为 19 天。接种第三剂或第四剂后没有病例报告,大多数患者在接种第一剂疫苗后被诊断为新发 MOGAD(76%)。虽然 COVID-19 疫苗接种可能是一个潜在的因果关系,但报告的病例与该患者之间存在显著差异,而且根据布拉德福德-希尔标准得出的因果关系评估结果也不太可能是因果关系。接种疫苗可能会掩盖潜在的原有自身免疫性疾病,例如该患者的脊髓病很可能是与新诊断的精原细胞瘤相关的副肿瘤综合征的一部分。
{"title":"Myelin Oligodendrocyte Glycoprotein G Antibody-Positive Paraneoplastic Myelopathy in Seminoma: A Case Report and Literature Review.","authors":"Umair Hamid, Jamir Pitton Rissardo, Luisa F Alviz, Ana Letícia Fornari Caprara, Tiffani S Franada","doi":"10.1177/19418744241288288","DOIUrl":"10.1177/19418744241288288","url":null,"abstract":"<p><p>Myelin oligodendrocyte glycoprotein-associated disorders (MOGAD) are autoimmune diseases that often manifest in the context of infections. They can also arise less commonly following vaccination but even more rarely in a paraneoplastic context. Herein, we will report a patient presenting with subacute inflammatory myelopathy after a fourth dose of the mRNA COVID-19 vaccine. Concurrently, a diagnosis of MOGAD was made with a metastatic abdominal seminoma. The patient was acutely treated with high-dose steroids followed by plasma exchange therapy and was subsequently started on a chemotherapy regimen for the underlying germ cell tumor. The patient had a complete resolution of neurological symptoms upon the last follow-up. Overall, 72 cases of COVID-19 vaccination associated with MOGAD were analyzed (median age at onset 39 years old; female to male ratio = 1.2:1). All cases occurred in adults except for an adolescent, with the majority occurring after vaccination with ChAdOx nCoV-19 (87%), and an average temporal profile between vaccination and symptom onset of 19 days. There were no reported cases after the third or fourth doses, and most patients were diagnosed with new-onset MOGAD after their first vaccine (76%). Although COVID-19 vaccination could be a potential causality, there are significant discrepancies between the reported cases and this patient, alongside the unlikely causality assessment obtained with the Bradford Hill criteria. Vaccination could unmask potential pre-existing autoimmune diseases, such as in this patient, where myelopathy was most likely part of a paraneoplastic syndrome associated with a newly diagnosed seminoma.</p>","PeriodicalId":46355,"journal":{"name":"Neurohospitalist","volume":" ","pages":"195-201"},"PeriodicalIF":0.7,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559457/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142630154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Deceptive Reassurance of a "Negative" Test - A Difficult Case Highlighting the BioFire© Meningitis/Encephalitis Panel and Medical Heuristics. 阴性 "检验的欺骗性保证--一个凸显 BioFire© 脑膜炎/脑炎检测小组和医学启发法的疑难病例。
IF 0.7 Q4 CLINICAL NEUROLOGY Pub Date : 2025-04-01 Epub Date: 2024-10-04 DOI: 10.1177/19418744241290274
Hai E Hoang

Purpose: Neurolisteriosis is a difficult neurologic infectious disease to diagnose. Here, we present a case in which the diagnosis was suspected, but repeated testing for the pathogen was negative. Ultimately the diagnosis was made after the patient iatrogenically worsened. Results: This prompted an investigation into the widely used diagnostic test, the BioFire© Meningitis/Encephalitis Panel. Although the company reports high sensitivities and specificities for the panel, real world studies have demonstrated insufficient evidence that all 14 pathogens tested on the panel have similar results. Conclusion: This case is a reminder of the heuristics involved in medicine and how with every medical advancement, clinicians should always go back to the fundamentals of history-taking and physical examinations to ensure no steps have been overlooked in the diagnosis and management of challenging cases.

目的:神经李斯特菌病是一种难以诊断的神经系统传染病。在此,我们介绍了一例疑似病例,但反复检测病原体均为阴性。最终在患者病情先天性恶化后确诊。结果:这促使我们对广泛使用的诊断测试--BioFire© 脑膜炎/脑炎面板--进行了调查。尽管该公司报告说该检测小组具有很高的灵敏度和特异性,但实际研究表明,没有足够的证据表明该小组检测的所有 14 种病原体都具有相似的结果。结论:这个病例提醒我们注意医学中的启发式方法,以及随着医学的不断进步,临床医生应始终坚持病史采集和体格检查的基本原则,以确保在诊断和处理具有挑战性的病例时不会忽略任何步骤。
{"title":"The Deceptive Reassurance of a \"Negative\" Test - A Difficult Case Highlighting the BioFire<sup>©</sup> Meningitis/Encephalitis Panel and Medical Heuristics.","authors":"Hai E Hoang","doi":"10.1177/19418744241290274","DOIUrl":"10.1177/19418744241290274","url":null,"abstract":"<p><p><b>Purpose:</b> Neurolisteriosis is a difficult neurologic infectious disease to diagnose. Here, we present a case in which the diagnosis was suspected, but repeated testing for the pathogen was negative. Ultimately the diagnosis was made after the patient iatrogenically worsened. <b>Results:</b> This prompted an investigation into the widely used diagnostic test, the BioFire© Meningitis/Encephalitis Panel. Although the company reports high sensitivities and specificities for the panel, real world studies have demonstrated insufficient evidence that all 14 pathogens tested on the panel have similar results. <b>Conclusion:</b> This case is a reminder of the heuristics involved in medicine and how with every medical advancement, clinicians should always go back to the fundamentals of history-taking and physical examinations to ensure no steps have been overlooked in the diagnosis and management of challenging cases.</p>","PeriodicalId":46355,"journal":{"name":"Neurohospitalist","volume":" ","pages":"163-166"},"PeriodicalIF":0.7,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559461/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142636170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dramatic Reanimation and Spontaneous Re-Canalization of a Fourth Ventricular Hemorrhage: "REVIVE" Phenomenon. 第四脑室出血的戏剧性苏醒和自发再堵塞:"REVIVE "现象。
IF 0.7 Q4 CLINICAL NEUROLOGY Pub Date : 2025-04-01 Epub Date: 2024-10-04 DOI: 10.1177/19418744241289972
Saif Salman, Andrea Janu, Rohan Sharma, Diane McLaughlin, Morgan Hardman, Rabih Tawk, W David Freeman

Background: Intraventricular hemorrhage is a calamitous type of stroke where bleeding into the ventricular system can be defined as: primary, if confined within the ventricles; or secondary, due to intracerebral hemorrhage extending from adjacent parenchyma. Intraventricular blood clot can lead to secondary insult and inflammatory responses that culminates in hydrocephalus as the most common cause of death.

Purpose: THerein, we report a patient with a high modified Graeb scale and low Glasgow coma scale. She spontaneously recanalized her fourth ventricle, decompressed her reticular activating system with remarkable spontaneous bilateral eye opening, and a consequently experienced a halfway drop in her mGS.

Results: This is the first reported case of a spontaneous recanalization of 4th ventricle obstruction secondary to IVH without intervention and subsequent dramatic neurological improvement. We believe that the apixaban primarily preserved the liquid state of hemorrhage and her presumed elevated ICP was sufficient to push out the liquified blood in the 4th ventricle into the upper spinal canal , recanalizing the 4th ventricle by continuously creating downward CSF pressure waves. Given the RAS location around the 4th ventricle, we hypothesize spontaneous decompression from the clot lysis triggered the RAS activation with sudden arousal manifested as spontaneous bilateral eyes opening. Hence, we refer to this as the reticular activating system reactivation after ventricular hemorrhage evacuation, or simply the "REVIVE" phenomenon.

Conclusion: This dramatic improvement from coma to awake state is worthy of recognition for future neurotherapeutic interventions.

背景:脑室内出血是中风的一种灾难性类型,出血进入脑室系统可定义为:原发性,如果局限于脑室内;或继发性,由于脑室内出血从邻近的实质组织扩展而来。脑室内血凝块可导致继发性损伤和炎症反应,最终导致脑积水,而脑积水是最常见的死亡原因。她的第四脑室自发再通,网状激活系统减压,双侧眼睛明显自发睁开,mGS也因此下降了一半:这是首例在未进行干预的情况下,继发于 IVH 的第四脑室阻塞自发再通畅,随后神经功能显著改善的病例。我们认为,阿哌沙班主要保留了出血的液态,而她推测的升高的ICP足以将第4脑室的液化血液推向椎管上部,通过持续产生向下的CSF压力波使第4脑室重新通畅。鉴于 RAS 位于第四脑室周围,我们推测血块溶解后的自发减压触发了 RAS 激活,并表现为自发双侧睁眼的突然唤醒。因此,我们将其称为脑室出血疏散后的网状激活系统再激活,或简称为 "REVIVE "现象:结论:这种从昏迷到清醒状态的显著改善值得在未来的神经治疗干预中加以肯定。
{"title":"Dramatic Reanimation and Spontaneous Re-Canalization of a Fourth Ventricular Hemorrhage: \"REVIVE\" Phenomenon.","authors":"Saif Salman, Andrea Janu, Rohan Sharma, Diane McLaughlin, Morgan Hardman, Rabih Tawk, W David Freeman","doi":"10.1177/19418744241289972","DOIUrl":"10.1177/19418744241289972","url":null,"abstract":"<p><strong>Background: </strong>Intraventricular hemorrhage is a calamitous type of stroke where bleeding into the ventricular system can be defined as: primary, if confined within the ventricles; or secondary, due to intracerebral hemorrhage extending from adjacent parenchyma. Intraventricular blood clot can lead to secondary insult and inflammatory responses that culminates in hydrocephalus as the most common cause of death.</p><p><strong>Purpose: </strong>THerein, we report a patient with a high modified Graeb scale and low Glasgow coma scale. She spontaneously recanalized her fourth ventricle, decompressed her reticular activating system with remarkable spontaneous bilateral eye opening, and a consequently experienced a halfway drop in her mGS.</p><p><strong>Results: </strong>This is the first reported case of a spontaneous recanalization of 4th ventricle obstruction secondary to IVH without intervention and subsequent dramatic neurological improvement. We believe that the apixaban primarily preserved the liquid state of hemorrhage and her presumed elevated ICP was sufficient to push out the liquified blood in the 4th ventricle into the upper spinal canal , recanalizing the 4th ventricle by continuously creating downward CSF pressure waves. Given the RAS location around the 4th ventricle, we hypothesize spontaneous decompression from the clot lysis triggered the RAS activation with sudden arousal manifested as spontaneous bilateral eyes opening. Hence, we refer to this as the reticular activating system reactivation after ventricular hemorrhage evacuation, or simply the \"REVIVE\" phenomenon.</p><p><strong>Conclusion: </strong>This dramatic improvement from coma to awake state is worthy of recognition for future neurotherapeutic interventions.</p>","PeriodicalId":46355,"journal":{"name":"Neurohospitalist","volume":" ","pages":"202-205"},"PeriodicalIF":0.7,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559456/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142630238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CONNECT: Coordinating Options for Neurovascular Patients Needing Electrophysiology Consults and Treatments. CONNECT:协调需要电生理学咨询和治疗的神经血管患者的选择。
IF 0.7 Q4 CLINICAL NEUROLOGY Pub Date : 2025-04-01 Epub Date: 2024-09-29 DOI: 10.1177/19418744241289973
Melissa Mortin, Ben Shifflett, Dawn M Meyer, Lovella Hailey, Stephanie Yoakum, Jonathan C Hsu, Brett C Meyer

Background and purpose: Though Event Monitors (EM) and Implantable Loop Recorders (ILR) are prevalent in stroke workups, complex processes to obtain placement of these device might result in delays. Our aim was to determine if the CONNECT (Coordinating Options for Neurovascular patients Needing Electrophysiology Consults and Treatments) pathway could improve Stroke-to-Electrophysiology (EP) communications, increase EM and ILR device placements prior to discharge, shorten placement time, and preserve satisfaction.

Methods: We assessed device placements when an EP consult was obtained [Pre-CONNECT (5/1/21-4/30/22), CONNECT (5/1/22-4/30/23)] for patients with stroke. In the Pre- period, consults were sent via EPIC electronic medical record (EMR), with additional direct communication when desired. In the CONNECT period, the pathway and module allowed for immediate communication between services. Outcomes included case rate, times, length of stay, and satisfaction. Hospital reports detailed Order to Activation (O-A) days. EM report review was used to obtain O-A time. Clinician satisfaction was assessed using Qualtrics survey. Patient satisfaction was assessed with Hospital Consumer Assessment of Health care Clinicians and Systems (HCAHPS) survey. Man-Whitney U test was used.

Results: 78 patients were included (30EM(38.5%), 48ILR(61.5%)). Age was 68 years (P = 0.58). For ILRs, inpatient placements prior to discharge increased (3Pre vs 51 CONNECT; P < 0.0001) as did outpatient placements (5 vs 16; P = 0.02). Order to Activation (O-A) time savings were significant for ILR overall (32 days vs 1 day; P = 0.03) and for Inpatient EM (13 days vs 3 days; P = 0.003). Time for consultant to view was 4 min and to respond was 6 min. Devices were placed at a median 6 hrs 32 min (EM: 4 hrs 19 min; ILR:7 hrs36 min). All (12/12) clinicians preferred the technique. Patient satisfaction improved on 13/19 (68%) questions.

Conclusions: There was a 1600% increase in ILR placements prior to discharge that was associated with the time period that the CONNECT process was in place. The robust improvement in ILR placements prior to discharge, high satisfaction, ease of use, closed loop communication, and respect for autonomy allowing more organic parallel discussions with patients improved clinician workflow which could potentially improve future risk reduction strategies.

背景和目的:虽然事件监测仪(EM)和植入式环路记录仪(ILR)在卒中治疗中很普遍,但安置这些设备的复杂过程可能会导致延误。我们的目的是确定 CONNECT(需要电生理学会诊和治疗的神经血管患者的协调选择)途径是否能改善卒中与电生理学(EP)之间的沟通,增加出院前 EM 和 ILR 装置的安置,缩短安置时间并保持满意度:方法: 我们评估了脑卒中患者在接受 EP 会诊[Pre-CONNECT (5/1/21-4/30/22)、CONNECT (5/1/22-4/30/23)]时的装置安置情况。在 "CONNECT 前 "阶段,咨询通过 EPIC 电子病历 (EMR) 发送,并在需要时进行额外的直接沟通。在 CONNECT 阶段,路径和模块允许服务部门之间进行即时沟通。结果包括病例率、时间、住院时间和满意度。医院报告详细列出了从下单到激活(O-A)的天数。EM 报告审查用于获取 O-A 时间。临床医生满意度通过 Qualtrics 调查进行评估。患者满意度通过 "医院消费者医疗保健临床医生和系统评估"(HCAHPS)调查进行评估。采用 Man-Whitney U 检验:共纳入 78 名患者(30EM(38.5%),48ILR(61.5%))。年龄为 68 岁(P = 0.58)。就 ILR 而言,出院前的住院治疗增加了(3Pre vs 51 CONNECT;P < 0.0001),门诊治疗也增加了(5 vs 16;P = 0.02)。对于 ILR 整体(32 天 vs 1 天;P = 0.03)和 EM 住院患者(13 天 vs 3 天;P = 0.003)而言,从下单到启动(O-A)所需时间的节省非常显著。顾问查看时间为 4 分钟,回复时间为 6 分钟。放置设备的时间中位数为 6 小时 32 分钟(EM:4 小时 19 分钟;ILR:7 小时 36 分钟)。所有临床医生(12/12)都喜欢这种技术。患者对13/19(68%)个问题的满意度有所提高:出院前ILR置管增加了1600%,这与CONNECT流程实施的时间段有关。出院前ILR置入率的显著提高、高满意度、易用性、闭环沟通以及尊重患者自主权使得与患者进行更有机的平行讨论改善了临床医生的工作流程,从而有可能改善未来的风险降低策略。
{"title":"CONNECT: Coordinating Options for Neurovascular Patients Needing Electrophysiology Consults and Treatments.","authors":"Melissa Mortin, Ben Shifflett, Dawn M Meyer, Lovella Hailey, Stephanie Yoakum, Jonathan C Hsu, Brett C Meyer","doi":"10.1177/19418744241289973","DOIUrl":"10.1177/19418744241289973","url":null,"abstract":"<p><strong>Background and purpose: </strong>Though Event Monitors (EM) and Implantable Loop Recorders (ILR) are prevalent in stroke workups, complex processes to obtain placement of these device might result in delays. Our aim was to determine if the CONNECT (Coordinating Options for Neurovascular patients Needing Electrophysiology Consults and Treatments) pathway could improve Stroke-to-Electrophysiology (EP) communications, increase EM and ILR device placements prior to discharge, shorten placement time, and preserve satisfaction.</p><p><strong>Methods: </strong>We assessed device placements when an EP consult was obtained [Pre-CONNECT (5/1/21-4/30/22), CONNECT (5/1/22-4/30/23)] for patients with stroke. In the Pre- period, consults were sent via EPIC electronic medical record (EMR), with additional direct communication when desired. In the CONNECT period, the pathway and module allowed for immediate communication between services. Outcomes included case rate, times, length of stay, and satisfaction. Hospital reports detailed Order to Activation (O-A) days. EM report review was used to obtain O-A time. Clinician satisfaction was assessed using Qualtrics survey. Patient satisfaction was assessed with Hospital Consumer Assessment of Health care Clinicians and Systems (HCAHPS) survey. Man-Whitney U test was used.</p><p><strong>Results: </strong>78 patients were included (30EM(38.5%), 48ILR(61.5%)). Age was 68 years (<i>P</i> = 0.58). For ILRs, inpatient placements prior to discharge increased (3Pre vs 51 CONNECT; <i>P</i> < 0.0001) as did outpatient placements (5 vs 16; <i>P</i> = 0.02). Order to Activation (O-A) time savings were significant for ILR overall (32 days vs 1 day; <i>P</i> = 0.03) and for Inpatient EM (13 days vs 3 days; <i>P</i> = 0.003). Time for consultant to view was 4 min and to respond was 6 min. Devices were placed at a median 6 hrs 32 min (EM: 4 hrs 19 min; ILR:7 hrs36 min). All (12/12) clinicians preferred the technique. Patient satisfaction improved on 13/19 (68%) questions.</p><p><strong>Conclusions: </strong>There was a 1600% increase in ILR placements prior to discharge that was associated with the time period that the CONNECT process was in place. The robust improvement in ILR placements prior to discharge, high satisfaction, ease of use, closed loop communication, and respect for autonomy allowing more organic parallel discussions with patients improved clinician workflow which could potentially improve future risk reduction strategies.</p>","PeriodicalId":46355,"journal":{"name":"Neurohospitalist","volume":" ","pages":"105-112"},"PeriodicalIF":0.7,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559453/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142630231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neurological Complications and Outcomes in Critically Ill Patients With COVID-19: Results From International Neurological Study Group From the COVID-19 Critical Care Consortium. COVID-19 重症患者的神经并发症和预后:COVID-19重症监护联盟国际神经学研究小组的研究结果。
IF 0.7 Q4 CLINICAL NEUROLOGY Pub Date : 2025-04-01 Epub Date: 2024-10-15 DOI: 10.1177/19418744241292487
Syed Ameen Ahmad, Yunis Mayasi, Thu-Lan Kelly, Nicole White, Jacky Suen, Denise Battaglini, Gianluigi Li Bassi, John F Fraser, Lavien Premraj, Rakesh C Arora, Diego Bastos, Glenn Whitman, Matthew Griffee, Jonathon P Fanning, Chiara Robba, Sung-Min Cho

Background: In this COVID-19 Critical Care Consortium (CCCC) sub-study, we qualified neurological complications associated with SARS-CoV2 infection.

Methods: The CCCC is an international, multicenter study. Eligible patients were COVID-19 patients admitted to intensive care units (ICU) across 23 centers between 1/7/2020 to 6/23/2022. Incidence of neurological complications was estimated as number of events per hospital days and per admission using Poisson regression. Associations between neurological complications and risk factors were assessed using multivariable Poisson regression.

Results: 713 patients were included. Median age = 56 years (interquartile range (IQR) = 45-65). Neurological complications reported in 61/480 patients (12.7%) with the majority being ischemic stroke (2.9%), intracranial hemorrhage (ICH) (2.8%), and seizures (2.6%). Multivariable analysis for neurological complications per admitted days showed comorbid neurological conditions (incidence rate ratio (IRR) = 6.35, 2.57-15.7) were an independent risk factor for ischemic stroke. Extracorporeal membrane oxygenation (IRR = 5.32, 1.52-18.6), low-middle income countries (LMIC) vs high income countries (HIC) (IRR = 4.70, 1.62-13.7), and age >55 (IRR = 3.66, 1.23-10.9) were independent risk factors for ICH. Co-morbid neurological conditions (IRR = 3.43, 1.11-10.6), LMIC vs HIC (IRR = 8.69, 2.15-35.2), July-December 2020 vs January-June 2020 (IRR = 0.17, 0.04-0.69) and age >55 (IRR = 4.05, 1.15-14.3) were independent risk factors for seizure.

Conclusions: Decision-making should incorporate salient risk factors to inform management of SARS-CoV2 infection and avoid neurological complications.

背景在这项 COVID-19 重症监护联盟(CCCC)子研究中,我们对与 SARS-CoV2 感染相关的神经系统并发症进行了鉴定:CCCC是一项国际性多中心研究。符合条件的患者是 2020 年 7 月 1 日至 2022 年 6 月 23 日期间在 23 个中心的重症监护病房(ICU)住院的 COVID-19 患者。神经系统并发症的发生率采用泊松回归法按住院天数和入院天数估算。采用多变量泊松回归评估神经系统并发症与风险因素之间的关系:结果:共纳入 713 名患者。中位年龄=56岁(四分位距(IQR)=45-65)。61/480例患者(12.7%)出现神经系统并发症,其中大部分为缺血性中风(2.9%)、颅内出血(ICH)(2.8%)和癫痫发作(2.6%)。对每住院日神经系统并发症的多变量分析表明,合并神经系统疾病(发病率比 (IRR) = 6.35,2.57-15.7)是缺血性中风的独立危险因素。体外膜氧合(IRR = 5.32,1.52-18.6)、中低收入国家(LMIC)与高收入国家(HIC)(IRR = 4.70,1.62-13.7)和年龄大于 55 岁(IRR = 3.66,1.23-10.9)是 ICH 的独立风险因素。合并神经系统疾病(IRR = 3.43,1.11-10.6)、低收入国家 vs 高收入国家(IRR = 8.69,2.15-35.2)、2020 年 7 月-12 月 vs 2020 年 1 月-6 月(IRR = 0.17,0.04-0.69)和年龄大于 55 岁(IRR = 4.05,1.15-14.3)是癫痫发作的独立风险因素:结论:决策过程中应考虑突出的风险因素,为处理 SARS-CoV2 感染和避免神经系统并发症提供依据。
{"title":"Neurological Complications and Outcomes in Critically Ill Patients With COVID-19: Results From International Neurological Study Group From the COVID-19 Critical Care Consortium.","authors":"Syed Ameen Ahmad, Yunis Mayasi, Thu-Lan Kelly, Nicole White, Jacky Suen, Denise Battaglini, Gianluigi Li Bassi, John F Fraser, Lavien Premraj, Rakesh C Arora, Diego Bastos, Glenn Whitman, Matthew Griffee, Jonathon P Fanning, Chiara Robba, Sung-Min Cho","doi":"10.1177/19418744241292487","DOIUrl":"10.1177/19418744241292487","url":null,"abstract":"<p><strong>Background: </strong>In this COVID-19 Critical Care Consortium (CCCC) sub-study, we qualified neurological complications associated with SARS-CoV2 infection.</p><p><strong>Methods: </strong>The CCCC is an international, multicenter study. Eligible patients were COVID-19 patients admitted to intensive care units (ICU) across 23 centers between 1/7/2020 to 6/23/2022. Incidence of neurological complications was estimated as number of events per hospital days and per admission using Poisson regression. Associations between neurological complications and risk factors were assessed using multivariable Poisson regression.</p><p><strong>Results: </strong>713 patients were included. Median age = 56 years (interquartile range (IQR) = 45-65). Neurological complications reported in 61/480 patients (12.7%) with the majority being ischemic stroke (2.9%), intracranial hemorrhage (ICH) (2.8%), and seizures (2.6%). Multivariable analysis for neurological complications per admitted days showed comorbid neurological conditions (incidence rate ratio (IRR) = 6.35, 2.57-15.7) were an independent risk factor for ischemic stroke. Extracorporeal membrane oxygenation (IRR = 5.32, 1.52-18.6), low-middle income countries (LMIC) vs high income countries (HIC) (IRR = 4.70, 1.62-13.7), and age >55 (IRR = 3.66, 1.23-10.9) were independent risk factors for ICH. Co-morbid neurological conditions (IRR = 3.43, 1.11-10.6), LMIC vs HIC (IRR = 8.69, 2.15-35.2), July-December 2020 vs January-June 2020 (IRR = 0.17, 0.04-0.69) and age >55 (IRR = 4.05, 1.15-14.3) were independent risk factors for seizure.</p><p><strong>Conclusions: </strong>Decision-making should incorporate salient risk factors to inform management of SARS-CoV2 infection and avoid neurological complications.</p>","PeriodicalId":46355,"journal":{"name":"Neurohospitalist","volume":" ","pages":"113-123"},"PeriodicalIF":0.7,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559469/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142630168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Episodic Coma in Lewy Body Disorders: An Observational Report. 路易体失调症的发作性昏迷:观察报告
IF 0.7 Q4 CLINICAL NEUROLOGY Pub Date : 2025-04-01 Epub Date: 2024-09-18 DOI: 10.1177/19418744241286579
Joseph H Friedman

Background: and Purpose: Episodes of unresponsiveness are one of several criteria used to diagnose dementia with Lewy bodies and are also seen in people with Parkinson's disease dementia. Patients examined during episodes of coma, whose evaluations found no other explanation than the neurological disorder, have not been described. This paper describes four cases, seen in the past two years. The objective is to bring this uncommon phenomenon to the attention of hospital based neurologists and to demonstrate that this may not be due to autonomic dysfunction.

Methods: These are brief case descriptions by medical personnel observing affected patients supplemented by family reports of similar episodes described on the internet.

Results: Four cases are described, all older men with either dementia with Lewy bodies or Parkinson's disease dementia, who had single, or multiple episodes of otherwise unexplained coma and were examined during a spell. IRB approval waived.

Conclusions: Episodic coma may occur in demented patients with an alpha-synucleinopathy and is the likely explanation when evaluations have found no other cause. This information will reassure the family and patient that this is the likely explanation but that spells may recur.

背景和目的:反应迟钝发作是诊断路易体痴呆症的几个标准之一,也见于帕金森病痴呆症患者。在昏迷发作期间接受检查的患者,其评估结果除神经紊乱外没有其他解释,这种情况尚未见报道。本文描述了过去两年中的四个病例。目的是让医院的神经科医生注意到这种不常见的现象,并证明这可能不是自律神经功能失调造成的:这些都是观察患者的医务人员对病例的简要描述,并以互联网上类似病例的家属报告作为补充:结果:本文描述了四个病例,均为患有路易体痴呆症或帕金森病痴呆症的老年男性患者,他们曾出现过一次或多次原因不明的昏迷,并在昏迷期间接受了检查。结论:结论:α-突触核蛋白病痴呆患者可能会出现发作性昏迷,当评估未发现其他原因时,发作性昏迷可能是一种解释。这些信息可以让家属和患者放心,这是可能的解释,但昏迷可能会再次发生。
{"title":"Episodic Coma in Lewy Body Disorders: An Observational Report.","authors":"Joseph H Friedman","doi":"10.1177/19418744241286579","DOIUrl":"10.1177/19418744241286579","url":null,"abstract":"<p><strong>Background: </strong>and Purpose: Episodes of unresponsiveness are one of several criteria used to diagnose dementia with Lewy bodies and are also seen in people with Parkinson's disease dementia. Patients examined during episodes of coma, whose evaluations found no other explanation than the neurological disorder, have not been described. This paper describes four cases, seen in the past two years. The objective is to bring this uncommon phenomenon to the attention of hospital based neurologists and to demonstrate that this may not be due to autonomic dysfunction.</p><p><strong>Methods: </strong>These are brief case descriptions by medical personnel observing affected patients supplemented by family reports of similar episodes described on the internet.</p><p><strong>Results: </strong>Four cases are described, all older men with either dementia with Lewy bodies or Parkinson's disease dementia, who had single, or multiple episodes of otherwise unexplained coma and were examined during a spell. IRB approval waived.</p><p><strong>Conclusions: </strong>Episodic coma may occur in demented patients with an alpha-synucleinopathy and is the likely explanation when evaluations have found no other cause. This information will reassure the family and patient that this is the likely explanation but that spells may recur.</p>","PeriodicalId":46355,"journal":{"name":"Neurohospitalist","volume":" ","pages":"100-104"},"PeriodicalIF":0.7,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559462/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142636168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond de Patient: A Lesson in Vigilance and Care. 超越病人:警惕与关怀的一堂课。
IF 0.7 Q4 CLINICAL NEUROLOGY Pub Date : 2025-04-01 Epub Date: 2025-01-05 DOI: 10.1177/19418744241310478
Mariana Peschard-Franco

A neurology resident reflects on a pivotal moment during the assessment of an elderly patient, when attention shifts unexpectedly to the patient's caregiver, his wife. The resident quickly recognizes a neurological deficit that could potentially be treated. Sensing the urgency, the resident rushes her to the emergency department, where immediate treatment enables the caregiver to regain her ability to continue caring for her husband. This experience teaches the resident a profound lesson about the importance of vigilance not only toward primary patients but also toward those quietly supporting them. It highlights how timely intervention can preserve the connections that bind families, emphasizing the role of healthcare providers in maintaining these bonds.

一位神经内科住院医师回想起在对一位老年病人进行评估的关键时刻,当注意力意外地转移到病人的照顾者——他的妻子身上。住院医生很快就发现了可能被治疗的神经缺陷。意识到情况的紧急,住院医生赶紧把她送到急诊科,在那里立即治疗使护理人员能够重新获得继续照顾她丈夫的能力。这次经历给住院医生上了深刻的一课,不仅要对初级病人保持警惕,而且要对那些默默支持他们的人保持警惕。它强调了及时干预如何能够维护维系家庭的联系,强调了医疗保健提供者在维持这些联系方面的作用。
{"title":"Beyond de Patient: A Lesson in Vigilance and Care.","authors":"Mariana Peschard-Franco","doi":"10.1177/19418744241310478","DOIUrl":"10.1177/19418744241310478","url":null,"abstract":"<p><p>A neurology resident reflects on a pivotal moment during the assessment of an elderly patient, when attention shifts unexpectedly to the patient's caregiver, his wife. The resident quickly recognizes a neurological deficit that could potentially be treated. Sensing the urgency, the resident rushes her to the emergency department, where immediate treatment enables the caregiver to regain her ability to continue caring for her husband. This experience teaches the resident a profound lesson about the importance of vigilance not only toward primary patients but also toward those quietly supporting them. It highlights how timely intervention can preserve the connections that bind families, emphasizing the role of healthcare providers in maintaining these bonds.</p>","PeriodicalId":46355,"journal":{"name":"Neurohospitalist","volume":" ","pages":"223-224"},"PeriodicalIF":0.7,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11701896/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pitfalls in the Evaluation of Respiratory Failure in Myasthenia Gravis Patients: A Case Series. 肌无力患者呼吸衰竭评估中的误区:病例系列。
IF 0.7 Q4 CLINICAL NEUROLOGY Pub Date : 2025-04-01 Epub Date: 2024-08-31 DOI: 10.1177/19418744241280528
Sanem Pinar Uysal, Yuebing Li

Objectives: To highlight the importance of recognizing different presentations of respiratory failure due to myasthenic and non-myasthenic etiologies in myasthenia gravis (MG) patients.

Methods: We describe 3 patients with different presentations of respiratory failure in MG.

Cases: Patient 1 is a 49-year-old female with longstanding MG who presented with lethargy and neck weakness without notable respiratory distress. She was found to be in hypercarbic respiratory failure, which improved with plasmapheresis treatment. Patient 2 is a 58-year-old female who presented with ptosis, dysphagia, and dyspnea requiring intubation. Her hypophonia and dyspnea persisted despite escalation in MG treatment, and further workup revealed glottal stenosis secondary to granulomatosis with polyangiitis. Patient 3 is an 85-year-old female with MG presenting with refractory hypoxia, which was secondary to a large patent foramen ovale resulting in right-to-left shunting.

Discussion: All 3 cases emphasize the role of clinical reasoning and careful analysis based on thorough history taking, detailed neurologic exam and comprehensive laboratory findings to determine the etiologies for respiratory dysfunction in MG and provide appropriate treatment.

Conclusion: A lack of overt signs of respiratory distress in MG does not rule out the presence of respiratory failure due to the sedating effect of hypercapnia. There is a need to consider alternative etiologies of hypoxia in MG patients if typical symptoms or signs of MG exacerbations are absent.

目的强调识别重症肌无力(MG)患者因肌无力和非肌无力病因导致的呼吸衰竭不同表现的重要性:我们描述了 3 例不同表现的 MG 呼吸衰竭患者:患者 1 是一名 49 岁的女性,患有长期的 MG,表现为嗜睡和颈部无力,但没有明显的呼吸困难。她被发现处于高碳酸血症呼吸衰竭状态,经浆血疗法治疗后病情有所好转。患者 2 是一名 58 岁的女性,出现上睑下垂、吞咽困难和呼吸困难,需要插管治疗。尽管增加了 MG 的治疗,但她的发音减弱和呼吸困难仍持续存在,进一步检查发现她的声门狭窄继发于肉芽肿伴多血管炎。患者3是一名85岁的女性MG患者,表现为难治性缺氧,继发于巨大的卵圆孔导致的右向左分流:讨论:这三个病例都强调了临床推理的作用,以及基于全面的病史采集、详细的神经系统检查和全面的实验室检查结果进行仔细分析,以确定 MG 呼吸功能障碍的病因并提供适当的治疗:结论:MG 缺乏明显的呼吸窘迫症状并不能排除高碳酸血症的镇静作用导致的呼吸衰竭。如果没有 MG 病情加重的典型症状或体征,则需要考虑 MG 患者缺氧的其他病因。
{"title":"Pitfalls in the Evaluation of Respiratory Failure in Myasthenia Gravis Patients: A Case Series.","authors":"Sanem Pinar Uysal, Yuebing Li","doi":"10.1177/19418744241280528","DOIUrl":"10.1177/19418744241280528","url":null,"abstract":"<p><strong>Objectives: </strong>To highlight the importance of recognizing different presentations of respiratory failure due to myasthenic and non-myasthenic etiologies in myasthenia gravis (MG) patients.</p><p><strong>Methods: </strong>We describe 3 patients with different presentations of respiratory failure in MG.</p><p><strong>Cases: </strong>Patient 1 is a 49-year-old female with longstanding MG who presented with lethargy and neck weakness without notable respiratory distress. She was found to be in hypercarbic respiratory failure, which improved with plasmapheresis treatment. Patient 2 is a 58-year-old female who presented with ptosis, dysphagia, and dyspnea requiring intubation. Her hypophonia and dyspnea persisted despite escalation in MG treatment, and further workup revealed glottal stenosis secondary to granulomatosis with polyangiitis. Patient 3 is an 85-year-old female with MG presenting with refractory hypoxia, which was secondary to a large patent foramen ovale resulting in right-to-left shunting.</p><p><strong>Discussion: </strong>All 3 cases emphasize the role of clinical reasoning and careful analysis based on thorough history taking, detailed neurologic exam and comprehensive laboratory findings to determine the etiologies for respiratory dysfunction in MG and provide appropriate treatment.</p><p><strong>Conclusion: </strong>A lack of overt signs of respiratory distress in MG does not rule out the presence of respiratory failure due to the sedating effect of hypercapnia. There is a need to consider alternative etiologies of hypoxia in MG patients if typical symptoms or signs of MG exacerbations are absent.</p>","PeriodicalId":46355,"journal":{"name":"Neurohospitalist","volume":" ","pages":"151-154"},"PeriodicalIF":0.7,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11561952/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142648957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cavitating Osmotic Demyelination Syndrome Following Correction of Chronic Hyponatremia in Sheehan's Syndrome: A Novel Case Report. 希恩综合征慢性低钠血症纠正后的空洞渗透性脱髓鞘综合征:新颖的病例报告。
IF 0.7 Q4 CLINICAL NEUROLOGY Pub Date : 2025-04-01 Epub Date: 2024-09-05 DOI: 10.1177/19418744241279491
Alamgir Shaikh, Moisés León-Ruiz, Ritwik Ghosh, Manoj Soren, Bilwatosh Mukhopadhyay, Shyamal Kanti Pal, Julián Benito-León

Introduction: Rapid correction of hyponatremia can result in osmotic demyelination syndrome (ODS). Sheehan's syndrome, a rare pituitary disorder caused by severe postpartum hemorrhage, is a potential cause of chronic hyponatremia. This case report describes a rare progression of extrapontine myelinolysis to central pontine myelinolysis, ultimately leading to ODS, following the correction of chronic hyponatremia associated with Sheehan's syndrome. Notably, this event occurred a decade after the initial postpartum hemorrhage due to placenta previa.

Case report: A 40-year-old woman from rural West Bengal, India, presented in a comatose state after five years of progressively worsening symptoms, including fatigue, gastrointestinal disturbances, cold intolerance, hair loss, and severe apathy, which had been misdiagnosed as psychogenic and treated with selective serotonin reuptake inhibitors. Two days before her admission to our hospital, she was diagnosed with a lower respiratory tract infection, dehydration, and severe hyponatremia (118 mEq/L) at a local private healthcare facility. Despite treatment with 3% sodium chloride and intravenous antibiotics, her condition deteriorated, prompting her transfer. At the time of hospitalization, the patient was diagnosed with chronic hyponatremia and hypopituitarism consistent with Sheehan's syndrome. This condition was attributed to a severe postpartum hemorrhage that occurred a decade prior, resulting from placenta previa. Initial MRI revealed extrapontine myelinolysis, and the correction of her "compensated" hyponatremia was identified as the cause of her neurological decline. Follow-up MRIs at 7 and 14 weeks confirmed the development of cavitating ODS.

Discussion: This case highlights several key points: First, even a relatively gradual correction of hyponatremia can precipitate ODS, especially in patients with chronic conditions like Sheehan's syndrome. Second, it underscores the importance of meticulous management of chronic hyponatremia to prevent severe neurological outcomes. Third, it illustrates the diagnostic challenges of differentiating Sheehan's syndrome from primary psychiatric disorders, particularly in low-resource settings where the syndrome remains prevalent. The case also emphasizes the need for awareness among healthcare providers about the potential for severe complications arising from even minor corrections in serum sodium levels in such patients.

简介快速纠正低钠血症可导致渗透性脱髓鞘综合征(ODS)。希恩综合征是一种由严重产后出血引起的罕见垂体疾病,也是慢性低钠血症的潜在病因。本病例报告描述了在纠正与希恩综合征相关的慢性低钠血症后,脑外髓鞘溶解发展为中枢性脑桥髓鞘溶解,最终导致 ODS 的罕见病例。值得注意的是,这一事件发生在最初因前置胎盘导致产后出血的十年之后:一名来自印度西孟加拉邦农村地区的 40 岁女性,在出现疲劳、胃肠道紊乱、不耐寒、脱发和严重冷漠等症状五年后出现昏迷状态,这些症状曾被误诊为精神疾病,并接受了选择性 5-羟色胺再摄取抑制剂治疗。入院前两天,她在当地一家私人医疗机构被诊断为下呼吸道感染、脱水和严重低钠血症(118 mEq/L)。尽管她接受了 3% 氯化钠和静脉注射抗生素的治疗,但病情仍然恶化,因此转院。住院时,患者被诊断为慢性低钠血症和垂体功能减退症,与希恩综合征一致。这种情况是由于十年前发生的严重产后出血导致的前置胎盘引起的。最初的核磁共振成像显示她患有脊髓外肌纤维溶解症,而纠正她的 "代偿性 "低钠血症被认为是导致她神经功能衰退的原因。7周和14周的随访核磁共振检查证实她患上了空洞型ODS:本病例强调了几个要点:讨论:本病例强调了几个要点:首先,即使是相对渐进地纠正低钠血症也可能诱发 ODS,尤其是像希恩综合征这样的慢性病患者。其次,该病例强调了对慢性低钠血症进行精细管理以防止出现严重神经系统后果的重要性。第三,该病例说明了将希恩综合征与原发性精神疾病相鉴别的诊断难题,尤其是在该综合征仍然普遍存在的低资源环境中。该病例还强调,医疗服务提供者需要认识到,这类患者的血清钠水平即使是轻微的修正,也有可能导致严重的并发症。
{"title":"Cavitating Osmotic Demyelination Syndrome Following Correction of Chronic Hyponatremia in Sheehan's Syndrome: A Novel Case Report.","authors":"Alamgir Shaikh, Moisés León-Ruiz, Ritwik Ghosh, Manoj Soren, Bilwatosh Mukhopadhyay, Shyamal Kanti Pal, Julián Benito-León","doi":"10.1177/19418744241279491","DOIUrl":"10.1177/19418744241279491","url":null,"abstract":"<p><strong>Introduction: </strong>Rapid correction of hyponatremia can result in osmotic demyelination syndrome (ODS). Sheehan's syndrome, a rare pituitary disorder caused by severe postpartum hemorrhage, is a potential cause of chronic hyponatremia. This case report describes a rare progression of extrapontine myelinolysis to central pontine myelinolysis, ultimately leading to ODS, following the correction of chronic hyponatremia associated with Sheehan's syndrome. Notably, this event occurred a decade after the initial postpartum hemorrhage due to placenta previa.</p><p><strong>Case report: </strong>A 40-year-old woman from rural West Bengal, India, presented in a comatose state after five years of progressively worsening symptoms, including fatigue, gastrointestinal disturbances, cold intolerance, hair loss, and severe apathy, which had been misdiagnosed as psychogenic and treated with selective serotonin reuptake inhibitors. Two days before her admission to our hospital, she was diagnosed with a lower respiratory tract infection, dehydration, and severe hyponatremia (118 mEq/L) at a local private healthcare facility. Despite treatment with 3% sodium chloride and intravenous antibiotics, her condition deteriorated, prompting her transfer. At the time of hospitalization, the patient was diagnosed with chronic hyponatremia and hypopituitarism consistent with Sheehan's syndrome. This condition was attributed to a severe postpartum hemorrhage that occurred a decade prior, resulting from placenta previa. Initial MRI revealed extrapontine myelinolysis, and the correction of her \"compensated\" hyponatremia was identified as the cause of her neurological decline. Follow-up MRIs at 7 and 14 weeks confirmed the development of cavitating ODS.</p><p><strong>Discussion: </strong>This case highlights several key points: First, even a relatively gradual correction of hyponatremia can precipitate ODS, especially in patients with chronic conditions like Sheehan's syndrome. Second, it underscores the importance of meticulous management of chronic hyponatremia to prevent severe neurological outcomes. Third, it illustrates the diagnostic challenges of differentiating Sheehan's syndrome from primary psychiatric disorders, particularly in low-resource settings where the syndrome remains prevalent. The case also emphasizes the need for awareness among healthcare providers about the potential for severe complications arising from even minor corrections in serum sodium levels in such patients.</p>","PeriodicalId":46355,"journal":{"name":"Neurohospitalist","volume":" ","pages":"188-194"},"PeriodicalIF":0.7,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11561923/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142648978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Neurohospitalist
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1